Beta Blocker Pharmacology and Clinical Implications

Introduction to Beta Blockers

• Beta-1 receptors are located primarily in the myocardium and control heart rate, contractility, and AV node conduction, while beta-2 receptors are located in vascular and bronchial smooth muscle, and their blockade causes vasoconstriction and bronchoconstriction, according to the American College of Cardiology 1, 2

Clinical Implications of Nonselective Blockade

• The American Heart Association recommends avoiding propranolol in patients with asthma or obstructive airway disease due to its nonselective blockade, which causes more bronchoconstriction than cardioselective agents 5, 6, 7
• The ACC/AHA guidelines distinguish propranolol from cardioselective beta blockers, such as metoprolol, atenolol, and bisoprolol, which are preferred in patients with reactive airway disease or COPD 3, 4, 6, 7, 8

Practical Prescribing Guidance

• The American College of Cardiology recommends using low doses of a beta-1–selective agent, such as metoprolol, rather than nonselective agents like propranolol, in patients with mild wheezing or COPD 3, 4, 8
• Cardioselective beta blockers, such as metoprolol and bisoprolol, are preferred over nonselective agents like propranolol for hypertension management, according to the American Heart Association 6, 7
• Propranolol has been studied and used effectively in acute coronary syndromes, though cardioselective agents are generally preferred, as stated by the American College of Cardiology 1, 2, 3